Zheng Zhou
-
- Air Quality and Health Impacts 6
- Pollution top 5%
- Energy and Environment Impacts 8
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 3
- Otorhinolaryngology top 5%
-
- Nanoplatforms for cancer theranostics 6
-
- Coronary Interventions and Diagnostics 4
-
- Immune cells in cancer 4
-
- Urban Transport and Accessibility 3
-
- Railway Engineering and Dynamics 3
- Co-authors
- Chen JiangRobert WolfLaura MauriAnn LovettTreacy S. SilbaughSharon‐Lise T. NormandKatya ZelevinskyPeixin Liu
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Advanced Materials (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Zheng Zhou
53 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Health, Toxicology and Mutagenesis 268
- Pollution 218
- Cardiology and Cardiovascular Medicine 317
- Biomaterials 160
- Otorhinolaryngology 53
Countries citing papers authored by Zheng Zhou
This map shows the geographic impact of Zheng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng Zhou more than expected).
Fields of papers citing papers by Zheng Zhou
This network shows the impact of papers produced by Zheng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng Zhou. The network helps show where Zheng Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zheng Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastomabreakdown → | 2025 | 21 |
| 6 | 2025 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 29 | |
| 10 | 2023 | 14 | |
| 11 | 2023 | 0 | |
| 12 | 2022 | 34 | |
| 13 | 2022 | 6 | |
| 14 | 2021 | 38 | |
| 15 | 2021 | 115 | |
| 16 | 2021 | 1 | |
| 17 | Risk Factors and a Nomogram for Predicting Intracranial Hemorrhage in Stroke Patients Undergoing Thrombolysis | 2020 | 1 |
| 18 | 2012 | 72 | |
| 19 | 2007 | 35 | |
| 20 | Users= Attitudes Toward Web Advertising: Effects of Internet Motivation and Internet Ability | 2002 | 50 |
About Zheng Zhou
Zheng Zhou is a scholar working on Pollution, Otorhinolaryngology and Business and International Management, having authored 58 papers that have together received 1.7k indexed citations. Recurring topics across this work include Energy and Environment Impacts (8 papers), Air Quality and Health Impacts (6 papers), Nanoplatforms for cancer theranostics (6 papers), Coronary Interventions and Diagnostics (4 papers), Immune cells in cancer (4 papers), Urban Transport and Accessibility (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Railway Engineering and Dynamics (3 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (268 citations), Pollution (218 citations) and Cardiology and Cardiovascular Medicine (317 citations). Zheng Zhou has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Chen Jiang, Robert Wolf, Laura Mauri, Ann Lovett, Treacy S. Silbaugh, Sharon‐Lise T. Normand, Katya Zelevinsky, Peixin Liu, Zhenhao Zhao and Tao Sun. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.